Dietary treatment of the irritable bowel syndrome

Current Treatment Options in Gastroenterology

Volumn 7, Issue 4, 2004, Pages 307-316

  Whorwell, Peter ^a   Lea, Richard ^a  

^a WYTHENSHAWE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CROMOGLYCATE DISODIUM; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; PLACEBO; PROBIOTIC AGENT;

ATOPY; COST EFFECTIVENESS ANALYSIS; DIARRHEA; DIET THERAPY; DIETARY FIBER; DISEASE EXACERBATION; FOOD ALLERGY; FOOD INTAKE; GASTROINTESTINAL DISEASE; HUMAN; IMMUNOASSAY; IRRITABLE COLON; LABORATORY TEST; NUTRITIONAL INTOLERANCE; REVIEW; SAFETY; SELF HELP;

EID: 4344561393     PISSN: 10928472     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11938-004-0017-1     Document Type: Review

References (74)

1. Drossman DA, Camilleri M, Mayer EA, Whitehead WE: AGA technical review on irritable bowel syndrome. Gastroenterology 2002, 123:2108-2131.
2. Lea R, Whorwell PJ: Quality of life in irritable bowel syndrome. Pharmacoeconomics 2001, 19:643-653.
3. Olden KW: Diagnosis of irritable bowel syndrome. Gastroenterology 2002, 122:1701-1714.
4. American Gastroenterological Association: Medical position statement: guidelines for the evaluation of food allergies. Gastroenterology 2001, 120:1023-1025.
5. Fasano A: Where have all the American celiacs gone? Acta Paediatr Suppl 1996, 412:20-24.
6. Sanders DS, Carter MJ, Hurlstone DP, et al.: Association of adult celiac disease with irritable bowel syndrome: a case-control study in patients fulfilling ROME II criteria referred to secondary care. Lancet 2001, 358:1504-1508.
7. Wahnschaffe U, Ullrich R, Riecken EO, Schulzke JD: Celiac disease-like abnormalities in a subgroup of patients with irritable bowel syndrome. Gastroenterology 2001, 121:1329-1338.
8. Shahbazkhani B, Forootan M, Merat S, et al.: celiac disease presenting with symptoms of irritable bowel syndrome. Aliment Pharmacol Ther 2003, 18:231-235.
9. Klein KB: Controlled treatment trials in the irritable bowel syndrome: a critique. Gastroenterology 1988, 95:232-241.
10. Poynard T, Regimbeau C, Benhamou Y: Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther 2001, 15:355-361.
11. Guthrie E, Creed F, Dawson D, Tomenson B: A controlled trial of psychological treatment for the irritable bowel syndrome. Gastroenterology 1991, 100:450-457.
12. Jackson JL, O'Malley PG, Tomkins G, et al.: Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis. Am J Med 2000, 108:65-72.
13. Whorwell PJ, Prior A, Faragher EB: Controlled trial of hypnotherapy in the treatment of severe refractory irritable-bowel syndrome. Lancet 1984, 2:1232-1234.
14. Lea R, Whorwell PJ: Serotonergic agents in the treatment of functional gastrointestinal disorders. Curr Treat Options Gastroenterol 2002, 5:293-300.
15. Dainese R, Galliani EA, De Lazzari F, et al.: Discrepancies between reported food intolerance and sensitization test findings in irritable bowel syndrome patients. Am J Gastroenterol 1999, 94:1892-1897.
16. Young E, Stoneham MD, Petruckevitch A, et al.: A population study of food intolerance. Lancet 1994, 343:1127-1130.
17. O'Sullivan M, Clayton N, Breslin NP, et al.: Increased mast cells in the irritable bowel syndrome. Neurogastroenterol Motil 2000, 12:449-457.
18. Weston AP, Biddle WL, Bhatia PS, Miner PB Jr: Terminal ileal mucosal mast cells in irritable bowel syndrome. Dig Dis Sci 1993, 38:1590-1595.
19. Petitpierre M, Gumowski P, Girard JP: Irritable bowel syndrome and hypersensitivity to food. Ann Allergy 1985, 54:538-540.
20. Barau E, Dupont C: Modifications of intestinal permeability during food provocation procedures in pediatric irritable bowel syndrome. J Pediatr Gastroenterol Nutr 1990, 11:72-77.
21. Roussos A, Koursarakos P, Patsopoulos D, et al.: Increased prevalence of irritable bowel syndrome in patients with bronchial asthma. Respir Med 2003, 97:75-79.
22. Niec AM, Frankum B, Talley NJ: Are adverse food reactions linked to irritable bowel syndrome? Am J Gastroenterol 1998, 93:2184-2190.
23. Burden S: Dietary treatment of irritable bowel syndrome: current evidence and guidelines for future practice. J Hum Nutr Diet 2001, 14:231-241.
24. Jones VA, McLaughlan P, Shorthouse M, et al.: Food intolerance: a major factor in the pathogenesis of irritable bowel syndrome. Lancet 1982, 2:1115-1117.
25. Bentley SJ, Pearson DJ, Rix KJ: Food hypersensitivity in irritable bowel syndrome. Lancet 1983, 2:295-297.
26. McKee AM, Prior A, Whorwell PJ: Exclusion diets in irritable bowel syndrome: are they worthwhile? J Clin Gastroenterol 1987, 9:526-528.
27. Atkinson W, Sheldon T, Shaath N, Whorwell PJ: IgG antibodies to food: a role in irritable bowel syndrome. Gut 2004, in press.
28. Jain NK, Rosenberg DB, Ulahannan MJ, et al.: Sorbitol intolerance in adults. Am J Gastroenterol 1985, 80:678-681.
29. Truswell AS, Seach JM, Thorburn AW: Incomplete absorption of pure fructose in healthy subjects and the facilitating effect of glucose. Am J Clin Nutr 1988, 48:1424-1430.
30. Fernandez-Banares F, Esteve-Pardo M, de Leon R, et al.: Sugar malabsorption in functional bowel disease: clinical implications. Am J Gastroenterol 1993, 88:2044-2050.
31. Goldstein R, Braverman D, Stankiewicz H: Carbohydrate malabsorption and the effect of dietary restriction on symptoms of irritable bowel syndrome and functional bowel complaints. Isr Med Assoc J 2000, 2:583-587.
32. Symons P, Jones MP, Kellow JE: Symptom provocation in irritable bowel syndrome: effects of differing doses of fructose-sorbitol. Scand J Gastroenterol 1992, 27:940-944.
33. Nelis GF, Vermeeren MA, Jansen W: Role of fructose-sorbitol malabsorption in the irritable bowel syndrome. Gastroenterology 1990, 99:1016-1020.
34. Dapoigny M, Stockbrugger RW, Azpiroz F, et al.: Role of alimentation in irritable bowel syndrome. Digestion 2003, 67:225-233.
35. Kajs TM, Fitzgerald JA, Buckner RY, et al.: Influence of a methanogenic flora on the breath H2 and symptom response to ingestion of sorbitol or oat fiber. Am J Gastroenterol 1997, 92:89-94.
36. Serra J, Azpiroz F, Malagelada JR: Impaired transit and tolerance of intestinal gas in the irritable bowel syndrome. Gut 2001, 48:14-19.
37. Suarez FL, Savaiano DA, Levitt MD: A comparison of symptoms after the consumption of milk or lactose-hydrolyzed milk by people with self-reported severe lactose intolerance. N Engl J Med 1995, 333(1):1-4.
38. Suarez FL, Savaiano DA, Levitt MD: Review article: the treatment of lactose intolerance. Aliment Pharmacol Ther 1995, 9:589-597.
39. Lewis MJ, Whorwell PJ: Bran: may irritate irritable bowel. Nutrition 1998, 14:470-471.
40. Heaton KW: Dietary fiber in perspective. Hum Nutr Clin Nutr 1983, 37:151-170.
41. Burkitt DP, Walker AR, Painter NS: Effect of dietary fiber on stools and the transit-times and its role in the causation of disease. Lancet 1972, 2:1408-1412.
42. Arffmann S, Andersen JR, Hegnhoj J, et al.: The effect of coarse wheat bran in the irritable bowel syndrome: a double-blind, cross-over study. Scand J Gastroenterol 1985, 20:295-298.
43. Cann PA, Read NW, Holdsworth CD: What is the benefit of coarse wheat bran in patients with irritable bowel syndrome? Gut 1984, 25:168-173.
44. Cook IJ, Irvine EJ, Campbell D, et al.: Effect of dietary fiber on symptoms and rectosigmoid motility in patients with irritable bowel syndrome: a controlled, crossover study. Gastroenterology 1990, 98:66-72.
45. Fowlie S, Eastwood MA, Prescott R: Irritable bowel syndrome: assessment of psychological disturbance and its influence on the response to fiber supplementation. J Psychosom Res 1992, 36:175-180.
46. Kruis W, Weinzierl M, Schussler P, Holl J: Comparison of the therapeutic effect of wheat bran, mebeverine, and placebo in patients with the irritable bowel syndrome. Digestion 1986, 34:196-201.
47. Lucey MR, Clark ML, Lowndes J, Dawson AM: Is bran efficacious in irritable bowel syndrome? A double-blind, placebo-controlled, crossover study. Gut 1987, 28:221-225.
48. Manning AP, Heaton KW, Harvey RF: Wheat fiber and irritable bowel syndrome: a controlled trial. Lancet 1977, 2:417-418.
49. Snook J, Shepherd HA: Bran supplementation in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther 1994, 8:511-514.
50. Soltoft J, Krag B, Gudmand-Hoyer E, et al.: A double-blind trial of the effect of wheat bran on symptoms of irritable bowel syndrome. Lancet 1976, 1:270-272.
51. Francis CY, Whorwell PJ: Bran and irritable bowel syndrome: time for reappraisal. Lancet 1994, 344:39-40.
52. Parisi GC, Zilli M, Miani MP, et al.: High-fiber diet supplementation in patients with irritable bowel syndrome (IBS): a multicenter, randomized, open trial comparison between wheat bran diet and partially hydrolyzed guar gum (PHGG). Dig Dis Sci 2002, 47:1697-1704.
53. Maxton DG, Morris JA, Whorwell PJ: Ranking of symptoms by patients with the irritable bowel syndrome. BMJ 1989, 299:1138.
54. Serra J, Salvioli B, Azpiroz F, Malagelada JR: Lipid-induced intestinal gas retention in irritable bowel syndrome. Gastroenterology 2002, 123:700-706.
55. Levitt MD, Furne J, Olsson S: The relation of passage of gas an abdominal bloating to colonic gas production. Ann Intern Med 1996, 124:422-424.
56. Lasser RB, Bond JH, Levitt MD: The role of intestinal gas in functional abdominal pain. N Engl J Med 1975, 293:524-526.
57. Steggerda FR: Gastrointestinal gas following food consumption. Ann N Y Acad Sci 1968, 150:57-66.
58. Ganiats TG, Norcross WA, Halverson AL, et al.: Does Beano prevent gas? A double-blind crossover study of oral alpha-galactosidase to treat dietary oligosaccharide intolerance. J Fam Pract 1994, 39:441-445.
59. Madden JA, Hunter JO: A review of the role of the gut microflora in irritable bowel syndrome and the effects of probiotics. Br J Nutr 2002, 88(suppl 1):S67-S72.
60. Nobaek S, Johansson ML, Molin G, et al.: Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome. Am J Gastroenterol 2000, 95:1231-1238.
61. Sen S, Mullan MM, Parker TJ, et al.: Effect of Lactobacillus plantarum 299v on colonic fermentation and symptoms of irritable bowel syndrome. Dig Dis Sci 2002, 47:2615-2620.
62. Kim HJ, Camilleri M, McKinzie S, et al.: A randomized, controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther 2003, 17:895-904.
63. Pimentel M, Chow EJ, Lin HC: Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J Gastroenterol 2000, 95:3503-3506.
64. Pimentel M, Chow EJ, Lin HC: Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome: a double-blind, randomized, placebo-controlled study. Am J Gastroenterol 2003, 98:412-419.
65. Di Stefano M, Strocchi A, Malservisi S, et al.: Nonabsorbable antibiotics for managing intestinal gas production and gas-related symptoms. Aliment Pharmacol Ther 2000, 14:1001-1008.
66. Mendall MA, Kumar D: Antibiotic use, childhood affluence, and irritable bowel syndrome (IBS). Eur J Gastroenterol Hepatol 1998, 10:59-62.
67. Stefanini GF, Prati E, Albini MC, et al.: Oral disodium cromoglycate treatment on irritable bowel syndrome: an open study on 101 subjects with diarrheic type. Am J Gastroenterol 1992, 87:55-57.
68. Stefanini GF, Saggioro A, Alvisi V, et al.: Oral cromolyn sodium in comparison with elimination diet in the irritable bowel syndrome, diarrheic type: multicenter study of 428 patients. Scand J Gastroenterol 1995, 30:535-541.
69. Lunardi C, Bambara LM, Biasi D, et al.: Double-blind, cross-over trial of oral sodium cromoglycate in patients with irritable bowel syndrome due to food intolerance. Clin Exp Allergy 1991, 21:569-572.
70. Huerta C, Garcia Rodriguez LA, Wallander MA, Johansson S: Users of oral steroids are at a reduced risk of developing irritable bowel syndrome. Pharmacoepidemiol Drug Saf 2003, 12:583-588.
71. Dunlop SP, Jenkins D, Neal KR, et al.: Randomized, double-blind, placebo-controlled trial of prednisolone in post-infectious irritable bowel syndrome. Aliment Pharmacol Ther 2003, 18:77-84.
72. Rao S, Welcher KZ, Stumbo P: Is coffee a colonic stimulant? Eur J Gastroenterol Hepatol 1998, 10:113-118.
73. Turnberg LA: Coffee and the gastrointestinal tract. Gastroenterology 1978, 75:529-530.
74. Talley NJ, Zinsmeister AR, Melton LJ III: Irritable bowel syndrome in a community: symptom subgroups, risk factors, and health care utilization. Am J Epidemiol 1995, 142:76-83.